British Columbia's Discovery Parks a good model for Australia
20 November, 2003 by Melissa TrudingerThe developer of British Columbia's Discovery Parks -- technology parks based on four campuses around the Canadian province -- believes the Discovery Park model would be advantageous to the development of Australian innovation and technology.
Strategic alliances between Victoria and China flagged
20 November, 2003 by Melissa TrudingerVictoria has signed a Memorandum of Understanding with Chinese sister state Jiangsu Province calling for strategic biotechnology alliances and joint ventures.
Academics should not fear industry involvement, says Canadian prof
20 November, 2003 by Melissa TrudingerAcademic researchers need a bit of encouragement to take the plunge into biotechnology, according to visiting University of British Columbia professor and biotechnology company founder Bob Hancock.
Dendritic Nanotechnologies granted self-assembly patents, gets funding boost
19 November, 2003 by Graeme O'NeillLeading US nanotechnology innovator Dendritic Nanotechnologies (DNT) continues to shine for its associate and 49.9 per cent owner Melbourne drug-developer Starpharma (ASX: SPL), after being granted a US patent on a new self-assembly technique for its giant, branched molecules, called dendrimers.
NZ's Blis targets Chinese market
04 November, 2003 by Graeme O'NeillDunedin biotech Blis Technologies has opened a portal into a potential AUD$200 million market by signing a deal with Auckland-based Asia-Pacific Biotech Distributors to take its antibacterial Throat Guard into China.
Ventracor raises $33m in rights issue
29 October, 2003 by Melissa TrudingerVentracor (ASX:VCR) has closed its renounceable rights issue, raising approximately AUD$33 million in an offer oversubscribed by $12 million.
Amrad aims to regain its footing
27 October, 2003 by Melissa TrudingerIf you'd asked him a year ago whether he could see himself as CEO of Amrad, Dr Peter Smith would have said not likely.
Gradipore faces shareholder-driven rebellion
24 October, 2003 by Melissa TrudingerJust weeks after a new CEO was appointed, embattled bioseparations company Gradipore has lost almost its entire board of directors in a shareholder-driven rebellion against the management of the company.
AusBiotech appoints policy and comms officer
15 October, 2003 by Melissa TrudingerIndustry association AusBiotech is moving to cement its role as an advocate for Australia's biotechnology industry, with the appointment of former SDA Biotech principal Paris Brooke to a newly created role in policy and communications.
Tight budget at Monash forces Metabolic sell-off
15 October, 2003 by Graeme O'NeillIn a drastic move to raise more funds for medical research, Monash University has sold off 6 million of its shares in promising Victorian biotech Metabolic Pharmaceuticals (ASX:MBP).
Two new businesses for biotech hub
13 October, 2003 by Tanya HollisSydney's Australian Technology Park biotech hub has grown to nine companies with two new businesses recently joining the BioFirst precinct.
Biotechs, VCs need to get real, says UK venture capitalist
09 October, 2003 by Melissa TrudingerBoth biotechnology companies and venture capitalists need to be more realistic about the opportunities and outcomes available to them, a British venture capitalist told a Melbourne forum yesterday.
IDG Life Sciences to launch new magazine
03 October, 2003 by Andrew BirminghamOctober marks the culmination of our plans to develop a comprehensive suite of life science media products for the Australian market place. Australian Biotechnology News is now well entrenched as the newspaper of choice for local biotechnology leaders. And our acquisition of Today's Life Science has given us great depth across the sector.
Optiscan receives first Pentax order
03 October, 2003 by Tanya HollisOptiscan Imaging's (ASX: OIL) partnership with Japan's Pentax Corporation to develop a flexible endomicroscope has taken another step forward with the Melbourne biotech receiving its first major order for the supply of components.
ComBio: Memories are made of this
02 October, 2003 by Graeme O'NeillIt seems that memories are made of... cadherins. While cadherins -- cell adhesion molecules -- do not actually store memories, at the very least they have a major role in organising the basic architecture of the brain, and the dense filigree of fine neural interconnections in which memories are mysteriously stored.
